Results 11 to 20 of about 257,172 (346)

The patients` perspective on home-based infusion: A longitudinal observational study in the German healthcare setting for patients with lysosomal storage disorders treated with enzyme replacement therapy

Molecular Genetics and Metabolism Reports, 2023
Background: Lysosomal storage diseases (LSDs), metabolic disorders resulting in build-up of endogenous waste and progressive organ damage, can be treated with intravenous enzyme replacement therapy (ERT).
Ria Heinrich, Franziska Claus, Tonio Schoenfelder   +2 more
doaj   +2 more sources

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

Molecular Genetics and Metabolism Reports, 2017
Fabry disease (FD) [OMIM 301500] is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in progressive multisystem accumulation of globotriaosylceramide (Gb3).
D. Concolino, L. Amico, M.D. Cappellini, E. Cassinerio, M. Conti, M.A. Donati, F. Falvo, A. Fiumara, M. Maccarone, R. Manna, A. Matucci, M.B. Musumeci, A. Nicoletti, R. Nisticò, F. Papadia, R. Parini, D. Peluso, L. Pensabene, A. Pisani, G. Pistone, M. Rigoldi, I. Romani, M. Tenuta, G. Torti, M. Veroux, E. Zachara   +25 more
doaj   +2 more sources

A task analysis of central line-associated bloodstream infection (CLABSI) surveillance in home infusion therapy. [PDF]

Am J Infect Control, 2022
Hannum SM, Oladapo-Shittu O, Salinas AB, Weems K, Marsteller J, Gurses AP, Cosgrove SE, Keller SC.   +7 more
europepmc   +2 more sources

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program

Antibiotics, 2022
Vancomycin is commonly used in outpatient parenteral antimicrobial therapy (OPAT) of Gram-positive infections. Therapeutic drug monitoring and adverse event monitoring pose a challenge. Outcome data of vancomycin in OPAT (vOPAT) are limited.
Lore Thijs, Charlotte Quintens, Lotte Vander Elst, Paul De Munter, Melissa Depypere, Willem-Jan Metsemakers, Georges Vles, Astrid Liesenborghs, Jens Neefs, Willy E. Peetermans, Isabel Spriet   +10 more
doaj   +2 more sources

Perspectives on central-line-associated bloodstream infection surveillance in home infusion therapy. [PDF]

Infect Control Hosp Epidemiol, 2019
Sara C. Keller MD, MPH, MSHP1 , Mary Alexander MA, RN, CRNI, CAE, FAAN2, Deborah Williams RN, MPH3, Clare Rock MD, MS4, Jennifer Han MD, MSCE5, Marin Schweizer PhD67, Teena Chopra MD, MPH8, Shiv Deol MHA, CPHQ3, David K.
Keller SC, Alexander M, Williams D, Rock C, Han J, Schweizer M, Chopra T, Deol S, Hirsch DK, Cosgrove SE, Gorski L.   +10 more
europepmc   +2 more sources

A new frontier: Central line-associated bloodstream infection surveillance in home infusion therapy. [PDF]

Am J Infect Control, 2018
Keller SC, Williams D, Rock C, Deol S, Trexler P, Cosgrove SE.   +5 more
europepmc   +2 more sources

Environmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy Patients. [PDF]

Infect Control Hosp Epidemiol, 2017
Keller SC, Williams D, Gavgani M, Hirsch D, Adamovich J, Hohl D, Krosche A, Cosgrove S, Perl TM.   +8 more
europepmc   +2 more sources

Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]

, 2014
Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana, Díaz Ballve, Damacia, Giovanni, Daniela Di, Gómez Raccio, Andrea, Moreira, Ileana, Regairaz, Lorena, Seminario, Gisela   +6 more
core   +1 more source

A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

Allergy, Asthma & Clinical Immunology, 2022
Immunoglobulin replacement therapy is the standard-of-care treatment for patients with primary immunodeficiency diseases who have impaired antibody production and function.
Kristin Epland, Daniel Suez, Kenneth Paris   +2 more
doaj   +1 more source

Implementing and validating a home-infusion central-line–associated bloodstream infection surveillance definition

Infection control and hospital epidemiology, 2023
Objective: Central-line–associated bloodstream infection (CLABSI) surveillance in home infusion therapy is necessary to track efforts to reduce infections, but a standardized, validated, and feasible definition is lacking.
S. Keller, S. Hannum, Kimberly Weems, Opeyemi Oladapo-Shittu, Alejandra B. Salinas, J. Marsteller, A. Gurses, E. Klein, I. Shpitser, C. Crnich, N. Bhanot, C. Rock, S. Cosgrove   +12 more
semanticscholar   +1 more source